Clara Chen
About Clara Chen
Clara Chen is the Director and WWHEOR Lead for Hematology at Bristol-Myers Squibb, with extensive experience in outcomes research and a Ph.D. in Epidemiology from UTHealth.
Current Role at Bristol-Myers Squibb
Clara Chen is currently serving as the Director, WWHEOR Lead Hematology at Bristol-Myers Squibb. She has held this position since April 2018 and works in Princeton Pike, New Jersey. In this role, she leads the Worldwide Health Economics and Outcomes Research (WWHEOR) initiatives for hematology.
Previous Positions at Bristol-Myers Squibb
Before her current role, Clara Chen held various positions at Bristol-Myers Squibb. From 2016 to 2018, she served as the Associate Director, WWHEOR Lead Myeloma in Princeton Pike, NJ. Prior to that, she was the Associate Director, US HEOR Lead Myeloma from 2014 to 2016 in Plainsboro, NJ.
Experience at McKesson Specialty Health
Clara Chen has extensive experience at McKesson Specialty Health. She worked as a Principal Outcomes Researcher in The Woodlands, TX, in 2014. Before that, she held the positions of Lead Outcomes Researcher from 2012 to 2013 and Outcomes Researcher from 2011 to 2012. Her earliest role at McKesson included serving as an Associate Outcomes Researcher from 2009 to 2010.
Early Career at US Oncology Network and Scott & White Hospital
Earlier in her career, Clara Chen worked at the US Oncology Network and Scott & White Hospital. She was a Senior Clinical Data Analyst at US Oncology from 2008 to 2009 and a Clinical Data Analyst in 2007 for 5 months. At Scott & White Hospital, she served as a Biostatistician in 2007 for 5 months.
Educational Background
Clara Chen holds a Ph.D. in Epidemiology from The University of Texas Health Science Center at Houston (UTHealth), which she earned between 2010 and 2016. Additionally, she has a Master's degree in Statistics from Texas A&M University, completed in 2006.